Evaluating the Plasma Pharmacokinetics of CRD-102 in patients with Heart Failure following long term administration

Trial Profile

Evaluating the Plasma Pharmacokinetics of CRD-102 in patients with Heart Failure following long term administration

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 17 Jan 2017

At a glance

  • Drugs CRD 102 (Primary)
  • Indications Heart failure
  • Focus Pharmacokinetics
  • Sponsors Cardiora
  • Most Recent Events

    • 01 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top